Description
Danegaptide, also known as GAP-134 and ZP1609, is an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation. Danegaptide mproves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. Danegaptide prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
Product information
CAS Number: 943134-39-2
Molecular Weight: 291.30
Formula: C14H17N3O4
Chemical Name: (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid
Smiles: NCC(=O)N1C[C@@H](C[C@H]1C(O)=O)NC(=O)C1C=CC=CC=1
InChiKey: BIZKIHUJGMSVFD-MNOVXSKESA-N
InChi: InChI=1S/C14H17N3O4/c15-7-12(18)17-8-10(6-11(17)14(20)21)16-13(19)9-4-2-1-3-5-9/h1-5,10-11H,6-8,15H2,(H,16,19)(H,20,21)/t10-,11+/m1/s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.